A clinical study for people living with alcohol-related liver disease (ARLD)
The STARLIGHT Study is testing a study drug to see if it can reduce the harmful effects of alcohol on the liver in adults with ARLD who: • Are 18 to 70 years of age. • Have drunk alcohol within the last 4 months. • Have been diagnosed with Alcohol-related Liver...
New research highlights stark inequalities in access to life-saving liver transplants
New research published today reveals a stark reality for people with chronic liver disease in England: despite facing a high risk of death after emergency hospital admission, the vast majority are not receiving a potentially life-saving liver transplant. Published in...
New study aims to improve liver health after menopause
Researchers from Imperial College London will look at a treatment called kisspeptin. They hope to find out if it has health benefits for post menopause women with signs of MASLD. After menopause, hormone changes can raise the risk of health issues. One of these is a...
Recreating metabolic liver disease in the lab: how the MIMIC project could change MASLD research
One of the most common causes of chronic liver disease in the UK is MASLD. This stands for metabolic dysfunction‑associated steatotic liver disease. It was previously known as non-alcoholic fatty liver disease or NAFLD. MASLD is closely linked to obesity and type 2...